View Cart  

CDRH to Strengthen Postmarket Surveillance, Plans Proactive Electronic Data Analysis

A A
Building on the enhanced tracking abilities that will be created by implementation of unique device identifiers (UDI), the FDA plans to begin rolling out by year’s end an enhanced postmarket surveillance program for medical devices.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00